202 related articles for article (PubMed ID: 27174600)
1. Clinical outcomes for patients with liver-limited metastatic colorectal cancer: Arguing the case for specialist hepatobiliary multidisciplinary assessment.
Thillai K; Repana D; Korantzis I; Kane P; Prachalias A; Ross P
Eur J Surg Oncol; 2016 Sep; 42(9):1331-6. PubMed ID: 27174600
[TBL] [Abstract][Full Text] [Related]
2. The Impact of a Hepatobiliary Multidisciplinary Team Assessment in Patients with Colorectal Cancer Liver Metastases: A Population-Based Study.
Engstrand J; Kartalis N; Strömberg C; Broberg M; Stillström A; Lekberg T; Jonas E; Freedman J; Nilsson H
Oncologist; 2017 Sep; 22(9):1067-1074. PubMed ID: 28550028
[TBL] [Abstract][Full Text] [Related]
3. Close collaboration between local and specialist multidisciplinary teams allows 'fast-tracking' of patients with colorectal liver metastases.
Vasudevan SP; Cresswell AB; Wright JM; Rees M; Stiff D; Wordley A; Motson RW
Colorectal Dis; 2013; 15(10):1253-6. PubMed ID: 23790093
[TBL] [Abstract][Full Text] [Related]
4. A 10-year study of outcome following hepatic resection for colorectal liver metastases - The effect of evaluation in a multidisciplinary team setting.
Lordan JT; Karanjia ND; Quiney N; Fawcett WJ; Worthington TR
Eur J Surg Oncol; 2009 Mar; 35(3):302-6. PubMed ID: 18328668
[TBL] [Abstract][Full Text] [Related]
5. Single-center multidisciplinary management of patients with colorectal cancer and resectable synchronous liver metastases improves outcomes.
Goyer P; Karoui M; Vigano L; Kluger M; Luciani A; Laurent A; Azoulay D; Cherqui D
Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):47-55. PubMed ID: 22521121
[TBL] [Abstract][Full Text] [Related]
6. Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
Isoniemi H; Uutela A; Nordin A; Lantto E; Kellokumpu I; Ovissi A; Kosunen J; Kallio R; Soveri LM; Salminen T; Ålgars A; Lamminmäki A; Halonen P; Ristamäki R; Räsänen J; Karjula H; Vaalavuo Y; Lavonius M; Osterlund P
Br J Surg; 2021 Jul; 108(7):817-825. PubMed ID: 33749772
[TBL] [Abstract][Full Text] [Related]
7. Variation in referral practice for patients with colorectal cancer liver metastases.
Young AL; Adair R; Culverwell A; Guthrie JA; Botterill ID; Toogood GJ; Lodge JP; Prasad KR
Br J Surg; 2013 Nov; 100(12):1627-32. PubMed ID: 24264786
[TBL] [Abstract][Full Text] [Related]
8. Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer.
Choti MA; Thomas M; Wong SL; Eaddy M; Pawlik TM; Hirose K; Weiss MJ; Kish J; Green MR
Ann Surg Oncol; 2016 Feb; 23(2):375-81. PubMed ID: 26561404
[TBL] [Abstract][Full Text] [Related]
9. Assessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data?
Aubin JM; Bressan AK; Grondin SC; Dixon E; MacLean AR; Gregg S; Tang P; Kaplan GG; Martel G; Ball CG
Can J Surg; 2018 Aug; 61(4):251-256. PubMed ID: 30067183
[TBL] [Abstract][Full Text] [Related]
10. Microwave ablation with or without resection for colorectal liver metastases.
Stättner S; Jones RP; Yip VS; Buchanan K; Poston GJ; Malik HZ; Fenwick SW
Eur J Surg Oncol; 2013 Aug; 39(8):844-9. PubMed ID: 23769976
[TBL] [Abstract][Full Text] [Related]
11. Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making.
Welsh FK; Tekkis PP; O'Rourke T; John TG; Rees M
Surg Oncol; 2008 Jul; 17(1):3-13. PubMed ID: 18222689
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatobiliary service centralization on treatment and outcomes in patients with colorectal cancer and liver metastases.
Vallance AE; vanderMeulen J; Kuryba A; Botterill ID; Hill J; Jayne DG; Walker K
Br J Surg; 2017 Jun; 104(7):918-925. PubMed ID: 28251644
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
Shah SA; Haddad R; Al-Sukhni W; Kim RD; Greig PD; Grant DR; Taylor BR; Langer B; Gallinger S; Wei AC
J Am Coll Surg; 2006 Mar; 202(3):468-75. PubMed ID: 16500252
[TBL] [Abstract][Full Text] [Related]
14. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
Martin RC; Edwards MJ; McMasters KM
Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489
[TBL] [Abstract][Full Text] [Related]
15. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
Gleisner AL; Choti MA; Assumpcao L; Nathan H; Schulick RD; Pawlik TM
Arch Surg; 2008 Dec; 143(12):1204-12. PubMed ID: 19075173
[TBL] [Abstract][Full Text] [Related]
16. [Radiofrequency ablation of colorectal liver metastases].
Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
[TBL] [Abstract][Full Text] [Related]
17. Resection or radiofrequency ablation of colorectal liver metastasis.
Jasarović D; Stojanović D; Mitrović N; Stevanović D
Vojnosanit Pregl; 2014 Jun; 71(6):542-6. PubMed ID: 25039107
[TBL] [Abstract][Full Text] [Related]
18. Resection of Liver Metastases in Colorectal Cancer in the Era of Expanding Systemic Therapy.
Jones RP; Poston GJ
Annu Rev Med; 2017 Jan; 68():183-196. PubMed ID: 27686016
[TBL] [Abstract][Full Text] [Related]
19. The management of resectable and unresectable liver metastases from colorectal cancer.
Kemeny N
Curr Opin Oncol; 2010 Jul; 22(4):364-73. PubMed ID: 20520544
[TBL] [Abstract][Full Text] [Related]
20. Effect of specialist decision-making on treatment strategies for colorectal liver metastases.
Jones RP; Vauthey JN; Adam R; Rees M; Berry D; Jackson R; Grimes N; Fenwick SW; Poston GJ; Malik HZ
Br J Surg; 2012 Sep; 99(9):1263-9. PubMed ID: 22864887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
